RCT of BLT Implants Used for Immediate vs Early Placement, Restored With Ceramic Crowns on Titanium Bonding Bases.
NCT ID: NCT05079542
Last Updated: 2021-10-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2015-10-05
2025-03-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Immediate implant placement
Implant is placed immediately after tooth extraction.
Timepoint of Implant placement of Bonelevel tapered implants
Implant surgery on different time points
Delayed implant placement
Implant is placed 8 weeks after tooth extraction.
Timepoint of Implant placement of Bonelevel tapered implants
Implant surgery on different time points
Lithium disilicate crown
Crown out of Lithiumdisilicate is inserted onto the implant.
Material for tooth restoration - Lithiumdisilicate glass ceramic or zirconia
Tooth restoration with a certain material
Zirconia Crown
Crown out of Zirconia is inserted onto the implant.
Material for tooth restoration - Lithiumdisilicate glass ceramic or zirconia
Tooth restoration with a certain material
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Timepoint of Implant placement of Bonelevel tapered implants
Implant surgery on different time points
Material for tooth restoration - Lithiumdisilicate glass ceramic or zirconia
Tooth restoration with a certain material
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ≥22 years of age
* Patient in a good general health
* Adequate bone quality and quantity for one-stage implant placement
* Patient with physical status PS1 and PS2 (according to Physical Status Classification System of the American Society of Anesthesiologists; Attachment 5)
* Adequate bone height of at least 1mm longer than the length of the study implant
* Capable of providing written informed consent.
* Obtained informed consent from the patient and committed to the study and the required follow-up visits.
Exclusion Criteria
* Thin mucosal biotype
* Anatomically not sufficient bone volume or height at implant site to achieve primary stability of the implant
* Pronounced esthetic expectations
* Lack of keratinized mucosa at implant site (\< 2mm oral and buccal)
* Women of childbearing potential with a positive urine pregnancy test
* Patients with inadequate oral hygiene or persistent intraoral infection
* Smokers exceeding 10 cigarettes / day, or equivalent; patients chewing tobacco
* Severe bruxism or clenching habits
* Presence a systemic disease or allergy (e.g. conditions requiring chronic routine prophylactic use of antibiotics or prolonged use of steroids, history of rheumatic heart disease, bacterial endocarditis, cardiac vascular anomalies, prosthetic joint replacements, etc.)
* Presence or history of receiving intravenous or subcutaneous antiresorptive agents, such as bisphosphonates
* Presence of mucosal diseases (e.g. erosive lichen planus) in the localized area around the study implant
* Patients with history of renal failure, bleeding disorders, metabolic bone disorder, uncontrolled endocrine disorders, HIV infection, leucocyte dysfunction and deficiencies, neoplastic disease requiring the use of radiation or chemotherapy, etc.
* Patients with alcohol or drug abuse
* Participation in any other clinical trial (drug or device) less that 30 days before implant insertion
22 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Geneva, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. med. dent. Malin Strasding
Principal Investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15-117
Identifier Type: -
Identifier Source: org_study_id